Building strategic partnerships to advance clinical excellence - our recent collaboration with Sharehereon Health has opened doors to high-quality refractory cancer care at Parkway Shanghai Hospital.
On 1 November, Parkway Shanghai Hospital partnered Professor Ding Gang, Founder of Sharehereon Health, to launch the Parkway Shanghai Hospital Oncology Center and Parkway International Refractory Oncology Consultation Center. This strategic collaboration unifies the expertise and resources of both healthcare organisations to deliver better oncology diagnosis and treatment for cancer patients.
“This strategic partnership is a harbinger of more great things to come. Refractory cancer, which is the cancer resistant to standard treatment, is a high potential segment in the private healthcare space and there’s great promise in it cementing our domain expertise in oncology,” shared Dr Prem Kumar Nair, Group CEO of IHH Healthcare, during his opening address.
Buoyed by this new development, IHH China will continue to innovate clinical practices, foster multidisciplinary cooperation and prioritise holistic patient care, to bring hope and improved outcomes to more cancer patients in Shanghai.
Related Stories
IHH Healthcare Deepens Commitment to Reduce Cancer Burden in Malaysia
Learn how our third memorandum of understanding with Ministry of Health Malaysia is expanding access to life-saving, advanced cancer care at 8 of our hospitals.
Fortis CEO Shares Vision for a Healthier India on NDTV
Here is a look at how Fortis is contributing to India’s healthcare transformation.
IHH Singapore Hits New Digital and Imaging Milestones
Across Singapore, IHH Healthcare is transforming care delivery through data, technology and frontline innovation.
Parkway Radiology Deploys Annalise.ai Chest X-ray AI Solution
Parkway Radiology has implemented the Annalise.ai Enterprise CXR solution across all its radiology clinics and hospital departments in Singapore. This represents the first network-wide deployment of the chest X-ray AI technology in the country.
Fortis Enhances Diagnostic and Paediatric Care at S L Raheja Hospital, Mumbai
S L Raheja Hospital, a Fortis Associate, has significantly expanded its diagnostic and paediatric capabilities with the launch of AI-enabled Digital Positron Emission Tomography–Computed Tomography (PET-CT), 3 Tesla Magnetic Resonance Imaging (MRI), and upgraded Neonatal Intensive Care Unit (NICU) and Paediatric Intensive Care Unit (PICU) services.
Acibadem Achieves Top Honours in Türkiye’s 2025 Industry Rankings
Acıbadem Healthcare Group continues to solidify its leadership in Türkiye’s healthcare sector, earning prestigious accolades in two major 2025 industry surveys.
